Medical Cannabis is the medical use of the Cannabis sativa, Cannabis indica and various other strains to relieve symptoms of diseases and treat their conditions. Medical cannabis is a category term for anything from dried cannabis flowers, cannabis oils, capsules and tablets to mouth spray.…
Medical Cannabis is the medical use of the Cannabis sativa, Cannabis indica and various other strains to relieve symptoms of diseases and treat their conditions. Medical cannabis is a category term for anything from dried cannabis flowers, cannabis oils, capsules and tablets to mouth spray. Cannabis-derivatives can provide a remedy for patients suffering from pain, cramps and/or nausea and many other illnesses and diseases, improving function and overall quality of life.
Patients find that medical cannabis from cannabis plants works better than simple medications containing cannabinoids, where active substances are isolated.
Worldwide consumer spending on legal cannabis was expected to reach an estimated $12.2 billion in 2018, jumping from a previous $9.5 billion in 2017, according to the 2019 update of the State of Legal Cannabis Markets, 6th Edition (SOLMM) report released by ArcView Market Research (ArcView Group) and BDS Analytics. ArcView Group now forecasts that spending growth will accelerate in 2019, jumping 38% to $16.9 billion, and continuing to $31.3 billion in 2022, growing at 26.7% compound annual growth rate (CAGR) over the five-year timeframe from 2017.
The market is expected to grow due to various reasons. One of the major ones being that the use of medical cannabis is becoming less stigmatized, showing favorable results for patients and also proving to be an environmentally-friendly choice. The number of countries legalizing its use is constantly increasing, trends in producing edible cannabis products are expanding and many governments are now supporting research and development in the industry.
The legality of cannabis for medical and recreational use varies per country, in terms of its possession, distribution and cultivation as well as how it can be consumed and the medical conditions for which it can be used. Countries that have legalized the medical use of cannabis include Australia, Canada, Chile, Colombia, Croatia, Cyprus, Finland, Germany, Greece, Israel, Italy, Lesotho, Luxembourg, North Macedonia, Norway, the Netherlands, New Zealand, Peru, Poland, South Africa and Thailand. Others have more restrictive laws that only allow the use of certain cannabis-derived pharmaceutical drugs. In the United States, 33 states and the District of Columbia have legalized the medical use of cannabis, but at the federal level its use remains prohibited for any purpose.
Therefore, over the forecast period, the change is expected to be slow, but more legal consumption of cannabis is expected in the developing market, which will ultimately drive the market.
CannaCor (Pty) Ltd is a company licensed as a prohibited drug operator. With over 50 000m2 of acquired land in Berea, Lesotho, the company will dedicate the land to the greenhouse or indoor cultivation of Cannabis. This company aims to become one of the top players in the industry, currently licensed and compliant with regulations to provide services in Canada, Europe and other global markets from this facility.
Through the development of a blockchain-based platform, CannaCor offers the necessary tools in the industry to provide trustability for consumers and the safety they so desperately need. In addition, blockchain offers a cost-effective solution to the supply-chain processes, capable of providing real-time information about the production process of Cannabis, while also guaranteeing the unalterability of the product. These unique features ensure an increase in revenue and provide higher levels of transparency for the company and its customers.
This will enable CannaCor to coordinate the activities required to accept raw materials, manufacture the product, test for quality, package for shipping and schedule for delivery. Furthermore, the ultimate goal of the company is to measure and capture the quality of products, production output and worker productivity to ensure the enterprise creates products that meet the highest quality standards. The cultivation life cycle will be carefully monitored, and important information will be captured at various stages in the cannabis plant’s life cycle.
Through the implementation of blockchain technology, CannaCor could potentially bring expected revenues for the industry to new highs by reducing production costs associated with the supply chain.
If you wish to know more about CannaCor, make sure to visit their website.
This is a paid-for submitted press release. CCN does not endorse, nor is responsible for any material included below and isn’t responsible for any damages or losses connected with any products or services mentioned in the press release. CCN urges readers to conduct their own research with due diligence into the company, product or service mentioned in the press release.
Last modified: January 14, 2020 1:04 PM UTC